Evidence map›Paper›PMID 41424801›Full record

ArticleFrontiers in molecular medicine2025

Association of specific HLA alleles in patients with interstitial cystitis suggesting autoimmunity.

Inna Tabansky Stern, Jiayao Wang, Robert M Moldwin, Jason M Kim, Jason H Singh, Derek C Tran, Souhel Najjar, Melis Akinci, Alexis Howard, Joseph E Duke-Cohan and 8 more

Abstract read
In one paragraph

Article in Frontiers in molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Inna Tabansky Stern *Department of Urology, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, United States.
Jiayao Wang *Department of Biomedical Informatics and Department of Systems Biology, Columbia University, New York, NY, United States.
Robert M MoldwinNorthwell Health, The Smith Institute for Urology, New Hyde Park, NY, United States.
Jason M KimDepartment of Urology, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, United States.
Jason H SinghNorthwell Health, The Smith Institute for Urology, New Hyde Park, NY, United States.
Derek C TranNorthwell Health, The Smith Institute for Urology, New Hyde Park, NY, United States.
Souhel NajjarDepartment of Neurology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, United States.
Melis AkinciTranslational Immunogenomics Laboratory, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
Alexis HowardTranslational Immunogenomics Laboratory, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
Joseph E Duke-CohanTranslational Immunogenomics Laboratory, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
Marwa BelhajTranslational Immunogenomics Laboratory, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
Jonathan StevensDepartment of Pathology, Brigham and Women's Hospital, Boston, MA, United States.
William J LaneDepartment of Pathology, Brigham and Women's Hospital, Boston, MA, United States.
Lori A BirderDepartment of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
Edwin K JacksonDepartment of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
Derin B KeskinTranslational Immunogenomics Laboratory, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
Guanglan ZhangHealth Informatics Lab, Department of Computer Science, Metropolitan College, Boston University, Boston, MA, United States.
Joel N H SternNorthwell Health, The Smith Institute for Urology, New Hyde Park, NY, United States.

Funding

Resource Development CoreU54DK137329 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Thomas R Kleyman · 2023 to 2026
$4.8M
NIDDK NIH HHS U54 DK137329
6 · The paper itself

Abstract

Interstitial cystitis/bladder pain syndrome (IC/BPS) with Hunner Lesions (Hunner Type Interstitial Cystitis or HIC) is characterized by lesions on the bladder wall. Previous work on these lesions identified B cells and monocytes within the lesion. However, the overall role of the adaptive immune system in the disorder remains uncertain. In this study, we performed HLA sequencing on 12 IC/BPS patients with HIC and 7 Non Hunner Type IC (NHIC) patients, and identified HLA-DQB1*02:02 and HLA-DRB1*07:01:01 have a significant association with HIC. This pilot study provides genetic evidence supporting a potential autoimmune component in HIC and may help define the pathogenesis of at least one subtype of IC/BPS, and lay the groundwork for identifying the etiology of IC/BPS as a disease complex. Identifying the mechanisms can also open new approaches to treatment. Identifying an HLA haplotype associated with HIC would indicate that it is autoimmune.

Indexed as

AutoimmunityHICHLAIC/BPSNHCI

Identifiers

PMID41424801
PMCPMC12712699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.